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ORIGINAL ARTICLE
Distinct HIV discordancy patterns by epidemic size in
stable sexual partnerships in sub-Saharan Africa
Hiam Chemaitelly,1 Ide Cremin,2 Jim Shelton,3 Timothy B Hallett,2
Laith J Abu-Raddad1,4,5
ABSTRACT
Objective To describe patterns of HIV infection among
stable sexual partnerships across sub-Saharan Africa
(SSA).
Methods The authors defined measures of HIV
discordancy and conducted a comprehensive
quantitative assessment of discordancy among
stable partnerships in 20 countries in SSA
through an analysis of the Demographic and Health
Survey data.
Results HIV prevalence explained at least 50% of the
variation in HIV discordancy, with two distinct patterns of
discordancy emerging based on HIV prevalence being
roughly smaller or larger than 10%. In low-prevalence
countries, approximately 75% of partnerships affected by
HIV are discordant, while only about half of these are
discordant in high-prevalence countries. Out of each 10
HIV infected persons, two to five are engaged in
discordant partnerships in low-prevalence countries
compared with one to three in high-prevalence countries.
Among every 100 partnerships in the population, one to
nine are affected by HIV and zero to six are discordant in
low-prevalence countries compared with 16e45 and
9e17, respectively, in high-prevalence countries. Finally,
zero to four of every 100 sexually active adults are
engaged in a discordant partnership in low-prevalence
countries compared with six to eight in high-prevalence
countries.
Conclusions In high-prevalence countries, a large
fraction of stable partnerships were affected by HIV and
half were discordant, whereas in low-prevalence
countries, fewer stable partnerships were affected by
HIV but a higher proportion of them were discordant. The
findings provide a global view of HIV infection among
stable partnerships in SSA but imply complex
considerations for rolling out prevention interventions
targeting discordant partnerships.
INTRODUCTION
The HIV epidemic in large swaths of sub-Saharan
Africa (SSA) is marked by substantial HIV preva-
lence in the general population.1 Recent commu-
nity surveys and data from voluntary counselling
and testing programmes in SSA revealed a consid-
erable proportion of individuals living in stable
discordant sexual partnerships (SDPs; ie, one
partner testing HIV seropositive, while the other
testing HIV seronegative).2 3
The levels of HIV discordancy among stable
partnerships affected by HIV and the reasons
behind the variability in HIV discordancy across
different settings remain inadequately established.
Moreover, there has been an intense debate about
the role of HIV seroconversions among SDPs in the
HIV epidemic and the priority of HIV prevention
interventions among discordant couples relative to
other prevention approaches such as among
commercial sex networks.4e7 Recent progress in
HIV prevention research has raised this debate to
a new height by demonstrating substantial efﬁca-
cies for several prevention interventions including
highly active antiretroviral therapy,8 pre-exposure
prophylaxis9 10 and microbicides.11 These prom-
ising ﬁndings in the context of the debate about the
contribution of SDPs to HIV incidence confront us
with the urgency to determine the patterns of HIV
infection among stable partnerships and the
distribution of discordancy across SSA.
The aim of this article is to describe the patterns
of discordancy in SSA using an ecological approach
to inform the debate about the role of discordancy
in the HIV epidemic and to provide a basis upon
which HIV prevention programmes among SDPs
can be considered.
METHODS
Overview and definitions
We described the distribution of prevalent HIV
infections among stable sexual partnerships in SSA
by analysing the Demographic and Health Survey
(DHS) data for 20 countries. A stable sexual part-
nership is deﬁned here as a spousal or cohabiting
partnership as per the DHS methodology which
deﬁnes a couple as a man and a woman living in
a consensual union within a household at the
time of the cross-sectional DHS survey.12 Every
couple in a polygamous partnership is considered as
a separate union. We followed an age-based deﬁni-
tion for the sexually active population which
include women aged 15e49 years and men aged
15e49, or 15e54, or 15e59 years based on the DHS
inclusion criteria for each country.13 We charac-
terise different aspects of discordancy by deﬁning
several population-level epidemiological measures
(ﬁgure 1A):
1. The proportion of SDPs among all stable
partnerships ðPallÞ deﬁned as
Pall ¼ number of stable HIV discordant partnershipstotal number of stable partnerships :
This measure conveys the level of discordancy
among all stable sexual partnerships in the
population.
< An additional appendix is
published online only. To view
this file please visit the journal
online (http://sti.bmj.com/
content/88/1.toc).
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2. The proportion of SDPs among all stable partnerships with
at least one HIV-infected individual in the partnership ðPdiscordÞ
deﬁned as
This measure conveys the proportion of stable partnerships
affected by HIV where the uninfected partner has not acquired
the infection yet but is at risk of acquiring it from the infected
partner in the future. The complement of Pdiscord (ie, 1 Pdiscord)
provides the proportion of stable partnerships affected by HIV
that are seropositive concordant.
3. The proportion of individuals engaged in SDPs among the
entire sexually active population ðlallÞ deﬁned as
lall ¼ number of individuals in stable HIV discordant partnershipstotal number of individuals :
This measure conveys the abundance of individuals who
are engaged in SDPs in the population. It can be expressed
approximately by
The approximation is valid provided there are minimal
differences in the rate of concurrent stable partnerships among
the sub-population engaged in SDPs versus the rest of the
population engaged in stable partnerships.
The abundance of HIV-infected individuals who can transmit
the infection to their uninfected partners can be expressed
approximately as 1=2lall. The approximation is valid provided,
among the population engaged in SDPs, there are minimal
differences in the number of persons who are HIV infected
versus those who are not HIV infected. These differences can
arise due to concurrency of sexual partnerships.
4. The proportion of HIV-infected individuals engaged in SDPs
among the entire HIV-infected population ðlposÞ deﬁned as
This measure conveys the level of engagement of HIV-
infected individuals in SDPs. It can be expressed approximately
by
The approximation is valid provided there are minimal
differences in the rate of concurrent stable partnerships among
the subpopulation engaged in SDPs versus the subpopulation
engaged in stable HIV concordant positive partnerships.
An additional useful measure is the prevalence of ‘positive
partnerships’, that is the proportion of partnerships affected by
HIV out of all stable partnerships ðPposÞ. This measure is not
independent of the above measures and can be obtained by
Ppos ¼ PallPdiscord:
Each of these measures describes discordancy from a different
angle as the nature of discordancy, and its implications in terms
of prevention efforts cannot be well understood without
appreciating the full picture drawn by all these measures
simultaneously. The supplementary online appendix includes
a heuristic and intuitive illustration of the application of these
measures and their approximations in a hypothetical popula-
tion. The appendix also demonstrates how the approximations
provide satisfactorily precise estimates for these measures. It
bears notice that each of these approximations is introduced
either because the DHS data do not include sufﬁcient informa-
tion to calculate the measure per its exact deﬁnition or because
the approximation minimises the effects of survey non-response
rates and incompleteness of HIV testing data.
Statistical analyses
Countries were considered for analysis based on the availability
of DHS HIV serological biomarker survey. For each country, we
analysed only the most recent DHS survey where HIV data were
collected. As a result, a total of 20 countries in SSA were
included: Burkina Faso (2003), Cameroon (2004), Democratic
Republic of Congo (2007), Cote d’Ivoire (2005), Ethiopia (2005),
Ghana (2003), Guinea (2005), Kenya (2008e2009), Lesotho
(2009), Liberia (2007), Malawi (2004), Mali (2006), Niger (2006),
Rwanda (2005), Senegal (2005), Sierra Leone (2008), Swaziland
(2006e2007), Tanzania (2007e2008), Zambia (2007) and
Zimbabwe (2005e2006).
We calculated country-speciﬁc demographic and epidemiolog-
ical indicators such as the size of the sexually active population,
the proportion of the sexually active population engaged in stable
partnerships (using the average rate of self-reported engagement
in stable partnerships for men and women), the proportion of
HIV-1-infected individuals engaged in stable partnerships (using
the average rate of self-reported engagement in stable partner-
ships for HIV-1-infected men and women), the distribution of
partnerships based on HIV-1 serostatus (concordant negative,
discordant or concordant positive), the number of HIV-1-
infected individuals and HIV-1 population prevalence. For this
purpose, we merged the DHS couple data set for each country
with the corresponding HIV-1 serostatus data set. We limited
our analysis to HIV-1 seropositivity. In addition, couples, where
only one of the partners had tested for HIV-1, were excluded
from our analyses. Where couple data sets could not be identi-
ﬁed, we matched individual data sets for men and women with
the corresponding HIV serostatus data set, before merging both
data sets using the husband line number as an identiﬁer to
form a couple data set with HIV serostatus information. This
procedure was performed based on established guidelines
for managing DHS data.12 We also applied the sampling
Pdiscord ¼ number of stable HIV discordant partnershipstotal number of stable partnerships with at least one HIV-infected individual:
lallyfraction of the sexually active population in stable partnerships3Pall:
lpos ¼ number of HIV-infected individuals in stable HIV discordant partnershipstotal number of HIV-infected individuals :
lposy
fraction of infected persons in stable partnerships3number of stable HIV discordant partnerships
number of stable HIV discordant partnerships þ 23number of stable HIV concordant positive partnerships:
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weights retrieved from the DHS data sets in our calculations of
demographic and epidemiological indicators.
RESULTS
Overall, the mean response rate was high across countries of SSA
and varied for the DHS surveys between 86.1% and 97.7% with
a mean of 92.9% and for HIV testing between 67.0% and 96.5%
with a mean of 83.8%. Women were more likely to participate in
the DHS surveys compared with men (mean of 95.2% vs 90.6%),
and this difference was statistically signiﬁcant for all countries.
Women were also more likely to undertake HIV testing
compared with men (mean of 86.8% vs 80.4%), and this differ-
ence was also statistically signiﬁcant for all countries. The rate
of incomplete or missing HIV testing information among
couples ranged from 2.2% to 33.8% with an average of 14.2%
across the countries. Information was missing for both partners
among 5.3% of the couples. In addition, men were more likely
than women to have incomplete or missing HIV testing infor-
mation (5.9% vs 3.0%), and the difference was statistically
signiﬁcant for 13 of the 20 countries.
Figure 1 Measures of discordancy among stable sexual partnerships across 20 countries in sub-Saharan Africa. (A) Schematic diagram describing
the presence of HIV discordancy among stable sexual partnerships in the sexually active population. (B) The proportion of HIV discordant
partnerships among all stable partnerships with at least one HIV-infected individual in the partnership (Pdiscord), and the proportion of all HIV-infected
individuals engaged in stable HIV discordant partnerships (lpos). (C) The proportion of stable discordant partnerships among all stable partnerships
ðPallÞ. (D) The proportion of individuals engaged in stable HIV discordant partnerships ðlallÞ. Countries are shown in order of increasing HIV
prevalence.
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Statistical analyses of DHS data also revealed variability in the
demographic and epidemiological measures of discordancy
across SSA. The proportion of adults reporting a current stable
sexual partnership varied widely (from 35.3% to 76.3%). In
addition to the well-described variation in HIV prevalence across
countries (0.5%e23.0%), variations in HIV discordancy
measures ranged from 36.3% to 87.8% for Pdiscord (ﬁgure 1B),
10.5% to 50.3% for lpos (ﬁgure 1B), 0.4% to 17.2% for Pall (ﬁgure
1C), 0.2% to 8.3% for lall (ﬁgure 1D) and 0.9% to 45.2% for Ppos.
Table 1 presents HIV prevalence and discordancy measures for
all 20 countries examined in this study.
Two suggestive patterns of HIV discordancy were discerned
based on HIV prevalence being above or below 10%. In countries
where HIV prevalence was <10% (low-prevalence countries),
the vast majority of stable partnerships affected by HIV were
discordant with a mean Pdiscord of 75.2% and a range between
48.4% and 87.8%. On the other hand, around half of these
partnerships were discordant in countries where HIV prevalence
exceeded 10% (high-prevalence countries), with a mean Pdiscord of
49.6% and a range between 36.3% and 58.5%. Similarly, high
levels of lpos were observed in low HIV prevalence countries
where a mean of 40.0% of all HIV-infected individuals were
engaged in SDPs (range between 21.3% and 50.3%) compared
with high-prevalence countries where the mean was 21.5%
(range between 10.5% and 32.4%).
These trends were corroborated by ﬁtting linear regressions
revealing statistically signiﬁcant declines in Pdiscord of 1.7%
(95% CI 2.4% to 1.0%) and in lpos of 1.3% (95% CI 1.9%
to 0.8%), associated with a 1% increase in HIV prevalence.
Figure 2 illustrates the decline in Pdiscord and lpos with respect to
HIV prevalence, which solely explains 56.1% and 56.3% of the
variations in Pdiscord and lpos, respectively. An exponential ﬁt (not
shown) explained 59.7% and 60.7% of the variation in each of
these measures, respectively.
Low-prevalence countries had also low levels of
Ppos ð0:9%e9:0%Þ, Pall ð0:4%e6:4%Þ and lall ð0:2%e3:8%Þ,
whereas high-prevalence countries had high levels of
Ppos ð16:1%e45:2%Þ, Pall ð9:3%e17:2%Þ and lall ð5:8%e8:3%Þ.
Indeed, out of every 100 stable sexual partnerships, a mean of
four were affected by HIVand a mean of three were identiﬁed as
discordant in low-prevalence countries compared with a mean of
29 and 13, respectively, in high-prevalence countries (table 1). In
addition, only a mean of two individuals of every 100 sexually
active adults were part of an SDP in low-prevalence countries
compared with seven of every 100 in high-prevalence countries
(table 1).
We conducted a stratiﬁed analysis of the direction of discor-
dancy by sex. Our calculations indicated that women are the
infected index partners in 49.4% of SDPs (range between 36.5%
and 72.1%). There was, however, no discernable trend in the
direction of discordancy by sex with respect to HIV prevalence
across SSA (data not shown).
DISCUSSION
We examined levels and variations in HIV discordancy measures
among stable sexual partnerships across 20 countries in SSA by
statistically analysing DHS data. Our analyses revealed that at
least 50% of the variability in the two key discordancy measures
(Pdiscord and lpos) can be explained by differences in HIV preva-
lence. Both discordancy measures showed a continuous grada-
tion with a steady decline associated with increasing HIV
prevalence. These results can be viewed for simplicity as
showing two distinct patterns of HIV discordancy for countries
with low compared with high HIV prevalence.
In low-prevalence countries, the majority of stable partner-
ships with at least one HIV-infected individual ðPdiscordÞ were
found discordant and a minority were concordant positive.
Meanwhile, about half of these partnerships were discordant in
high-prevalence countries. Similarly, about one of three HIV-
infected individuals was engaged in an SDP in low-prevalence
countries (ie, lpos) compared with about one of ﬁve in high-
prevalence countries. Our results are in line with distinct
empirical evidence from different communities in SSA
suggesting a range for Pdiscord between 30% and 90%, with
a pattern of about half of partnerships affected by HIV being
discordant in high-prevalence areas.3 14e16
Our analyses also revealed that out of every 100 stable part-
nerships, four are affected by HIV in low-prevalence countries
and 29 in high-prevalence countries. Out of all stable partner-
ships, about one in every 37 is discordant ðPallÞ in low-prevalence
Figure 2 Variability in measures of
discordancy with respect to HIV
prevalence across 20 countries in sub-
Saharan Africa. Variation with respect
to HIV prevalence of the proportion of
HIV discordant partnerships among all
stable partnerships with at least one
HIV-infected individual in the
partnership (Pdiscord) and of the
proportion of HIV-infected individuals
that are engaged in stable HIV
discordant partnerships among the
sexually active population (lpos).
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countries compared with about one in every seven in high-
prevalence countries. These results agree with existing empirical
evidence suggesting that >10% of partnerships in high-preva-
lence areas may be discordant.2 3 17 Moreover, our ﬁndings show
that approximately two of every 100 sexually active adults ðlallÞ
are engaged in an SDP in low-prevalence countries compared
with about seven of every 100 in high-prevalence countries.
In agreement with ﬁndings of Eyawo et al14 for 14 countries in
SSA, our analyses revealed that women are equally likely as men
to be the infected partner in a discordant partnership (46% (95%
CI 41% to 51%) in Eyawo et al vs 49.4% (95% CI 44.5% to
54.3%) in our study). Assuming that HIV male to female
transmission probability is equal to that of female to male
transmission probability, as suggested by empirical data,18 these
results suggest that women may be equally likely as men to
bring the infection to the stable partnership from sources
external to the partnership.
While our study has described discordancy patterns, the
nature and balance of drivers behind these observed patterns are
not clear and may only be subject to speculative interpretation.
Different hypotheses may explain the observed trends. The
potential variability in HIV transmission probability per coital
act across SSA affects the likelihood of an SDP becoming
concordant positive and may explain part of the observed
patterns. HIV transmission is dependent on multiple biological
factors such as male circumcision,19e21 presence of other sexu-
ally transmitted diseases,22 23 presence of tropical co-infections
that increase HIV viral load,24 viral factors,25 host genetics25 and
host immunology.25 Behavioural factors and uptake of preven-
tion interventions such as frequency of coital acts, temporal
changes in sexual behaviour and condom use can also impact the
likelihood of transmission within a partnership. All these factors
may vary across different settings in SSA.
The likelihood of infection by external partners might also
contribute to the observed variations in discordancy measures
across SSA. Indeed, the likelihood of acquiring HIV from
a source external to the SDP increases with HIV population
prevalence.
The chance of partnership formation between infected and
uninfected partners may also explain part of the observed
dynamics. Assuming random mixing in a population with an
HIV prevalence of ‘p’, Pdiscord ¼ 2pð1 pÞ=ð2pð1 pÞ þ p2Þ,
Pall ¼ 2pð1 pÞ, and Ppos ¼ 2pð1 pÞ þ p2. Accordingly, the
dependence on HIV prevalence of these expressions may explain
part of the scale and variability of the discordancy measures.
One hypothesis might be that HIV incidence rate, that is, the
annual risk of infection for an individual from all sources, might
have declined in some countries with high HIV prevalence. In
a setting where HIV incidence rate is declining, it is possible that
the rate at which partnerships involving uninfected partners
become discordant is less than the rate at which existing SDPs
become concordant positive. This potential imbalance in the
ﬂow between concordant negative partnerships becoming
discordant versus SDPs becoming concordant positive can lead to
lower Pdiscord and lpos as existing SDPs become concordant positive
at a faster rate than new partnerships become discordant. This
suggestion is consistent with empirical evidence for declining
HIV incidence in several countries at high HIV prevalence.1 26 27
Mathematical models would be able to examine whether this
could be consistent with a fuller analysis of the data and through
an examination of data collected in future surveys.
Several study limitations might have affected our ﬁndings. First,
our selection of the DHS survey for the different countries was
constrained by the availability of HIV biomarker information at
any particular survey. This limited our ability to consider more
countries in SSA for analysis with more recent DHS surveys. In
addition, we explored the variation in discordancy measures by
HIV prevalence across different countries in SSA through an
ecological analysis which uses aggregate rather than individual
level data and, hence, limits our ability to establish causality.
Furthermore, intra-country epidemic heterogeneity is present and
may affect the validity of a national-level analysis using DHS data.
Given the multiple logistical difﬁculties in conducting DHS
surveys, some of our discordancy measures may be biased due to
inherent biases in the data such as the variability in response
rates to HIV testing28 29 where, in countries such as Malawi
and Zimbabwe, low response rates of 67% and 70%, respectively,
have been recorded. Moreover, the higher likelihood of
women to undertake HIV testing might have also reduced the
probability of identifying partnerships affected by HIV.
Our ﬁndings might also be sensitive to non-random selection
bias where urban populations and individuals with prior HIV
testing may be more likely to refuse testing.30 31 We conducted
further comparative analyses to detect underlying non-random
epidemiological or socio-demographic differences between
couples with and without complete HIV serostatus information.
The comparisons indicated that for most countries, no signiﬁ-
cant differences exist between both groups with respect to age.
Yet, couples with higher education and living in urban areas
were less likely to have complete HIV serostatus information.
Despite these limitations, the DHS surveys are among the most
methodologically rigorous surveys available in SSA.32
Discordant couples are a key population for HIV prevention
programmes and several major randomised clinical trials have
established substantial efﬁcacies of several prevention interven-
tions that could beneﬁt this population group.8e11 Our ﬁndings
have implications for how such prevention interventions can be
translated into programmes for SDPs, and in the population at
large, and form a base upon which the impact of future HIV
intervention programmes can be quantiﬁed. Our results suggest
complex considerations for the implementation of HIV preven-
tion interventions among SDPs. While the majority of partner-
ships affected by HIV are discordant in low HIV prevalence
settings, their enrolment in prevention interventions constitute
a major logistical challenge since the absolute number and the
proportion of all sexual partnerships that are discordant are small.
Conversely, while the number and proportion of all sexual part-
nerships that are discordant are large in high-prevalence settings,
only about half of partnerships affected by HIV are discordant
and only about a ﬁfth of all HIV-infected individuals are in SDPs.
Key messages
< At least 50% of the variation in HIV discordancy can be
explained by differences in HIV prevalence.
< In high HIV prevalence countries, which make up the large
majority of HIV-infected individuals, most HIV-infected
individuals are not in stable discordant couples.
< In high HIV prevalence countries, a large fraction of stable
partnerships are affected by HIV and half are discordant.
< In low HIV prevalence countries, a small fraction of stable
partnerships are affected by HIV, but the vast majority of them
are discordant.
< Complex considerations exist for rolling out prevention
interventions targeting discordant partnerships.
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Although prevention interventions aiming at the protection
of the seronegative individual in an SDP would reduce HIV
incidence among discordant partnerships, quantifying the
impact of such interventions at the population level requires
further empirical epidemiological evidence and thorough math-
ematical modelling analyses. Moreover, the feasibility of
prevention interventions targeting individuals engaged in SDPs
must factor the abundance of discordancy, the ease and expense
of reaching these individuals and the labour-intensiveness and
long-term effectiveness of these interventions.
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